Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.09.2023 | Case report

Romosozumab

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kobayakawa T, et al. Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration. Modern rheumatology / the Japan Rheumatism Association 33 : 96-103, No. 1, 2023. Available from: URL: https://doi.org/10.1093/mr/roac014 Kobayakawa T, et al. Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration. Modern rheumatology / the Japan Rheumatism Association 33 : 96-103, No. 1, 2023. Available from: URL: https://​doi.​org/​10.​1093/​mr/​roac014
Metadaten
Titel
Romosozumab
Lack of efficacy: case report
Publikationsdatum
01.09.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-45985-7

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs